Deliver Your News to the World

Proposed change to Supervisory Board


Lars Rebien Sørensen, current Deputy Chairman of the Supervisory Board, has notified the Supervisory Board that he is not standing for re-election at the Annual General Meeting on 13 March 2019.

The Supervisory Board will propose the election of Lars Fruergaard Jørgensen as a new member. Lars Fruergaard Jørgensen is President and CEO of Novo Nordisk A/S.

Chairman of the Supervisory Board Flemming Besenbacher says: “I’d like to thank Lars Rebien Sørensen for his contribution to the Board during his tenure. I’m very pleased that we’re able to propose a strong replacement. Lars Fruergaard Jørgensen’s expertise and management experience will be valuable for the future work of the Supervisory Board.”


( Press Release Image: )


This news content was configured by WebWire editorial staff. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.